article Open AccessTop 1% cited
The molecular portraits of breast tumors are conserved across microarray platforms
BMC Genomics · 2006 · Vol. 7(1) · pp. 96–96
Zhiyuan Hu✉(UNC Lineberger Comprehensive Cancer Center)Cheng Fan(University of North Carolina at Chapel Hill)Daniel Oh(UNC Lineberger Comprehensive Cancer Center)J. S. Marron(University of North Carolina at Chapel Hill)Xiaping He(UNC Lineberger Comprehensive Cancer Center)Bahjat F. Qaqish(University of North Carolina at Chapel Hill)Chad Livasy(University of North Carolina at Chapel Hill)Lisa A. Carey(University of North Carolina at Chapel Hill)Evangeline Reynolds(University of North Carolina at Chapel Hill)Lynn G. Dressler(University of North Carolina at Chapel Hill)Andrew B. Nobel(University of North Carolina at Chapel Hill)Joel S. ParkerMatthew G. Ewend(University of North Carolina at Chapel Hill)Lynda Sawyer(University of North Carolina at Chapel Hill)Junyuan Wu(University of North Carolina at Chapel Hill)Yudong Liu(UNC Lineberger Comprehensive Cancer Center)Rita Nanda(University of Chicago)Maria Tretiakova(University of Chicago)Alejandra Ruiz Orrico(Thomas Jefferson University)Donna Dreher(Thomas Jefferson University)Juan Palazzo(Thomas Jefferson University)Laurent Perreard(ARUP Laboratories (United States))Edward William Nelson(University of Utah)Mary C. Mone(University of Utah)Heidi J. Hansen(University of Utah)Michael E. Mullins(University of Utah)John F. Quackenbush(University of Utah)Matthew J. Ellis(Washington University in St. Louis)Olufunmilayo I. Olopade(University of Chicago)Philip S. Bernard(University of Utah)Charles M. Perou(UNC Lineberger Comprehensive Cancer Center)
Abstract
This study validates the "breast tumor intrinsic" subtype classification as an objective means of tumor classification that should be translated into a clinical assay for further retrospective and prospective validation. In addition, our method of combining existing data sets can be used to robustly validate the potential clinical value of any new gene expression profile.
Gene expression and cancer classificationMolecular Biology Techniques and ApplicationsAI in cancer detectionBreast cancerDNA microarrayBiologyData setGene expression profilingMicroarray analysis techniquesComputational biologyGeneComputer scienceBioinformatics
MeSH terms
Breast NeoplasmsFemaleHumansPredictive Value of TestsResearch DesignReproducibility of ResultsGene Expression Regulation, NeoplasticCluster AnalysisSurvival AnalysisConserved SequenceSample SizeGenetic Predisposition to DiseaseOligonucleotide Array Sequence AnalysisGenes, Neoplasm
Funding
- National Science Foundation
- Breast Cancer Research Foundation
- National Institutes of Health
- University of North Carolina at Chapel Hill
- National Cancer Institute
- National Institute of Environmental Health Sciences
Citations
1,463
FWCI
33.94
field-weighted impact
References
51
Percentile
100%
vs. same field & year
Citations per year
Cited by
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype
Clinical Cancer Research · 2008 · 1,187 citations
bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer
Breast Cancer Research and Treatment · 2011 · 428 citations
Tumor cell-produced matrix metalloproteinase 9 (MMP-9) drives malignant progression and metastasis of basal-like triple negative breast cancer
Oncotarget · 2014 · 364 citations
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer
Clinical Cancer Research · 2010 · 818 citations
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Journal of Clinical Investigation · 2011 · 5,405 citations
[Retracted] Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures
BioMed Research International · 2022 · 531 citations
Endocrine-Therapy-Resistant ESR1 Variants Revealed by Genomic Characterization of Breast-Cancer-Derived Xenografts
Cell Reports · 2013 · 618 citations
Basal-like Breast cancer DNA copy number losses identify genes involved in genomic instability, response to therapy, and patient survival
Breast Cancer Research and Treatment · 2011 · 905 citations
References
Gene Expression Signature of Fibroblast Serum Response Predicts Human Cancer Progression: Similarities between Tumors and Wounds
PLoS Biology · 2004 · 953 citations
Missing value estimation methods for DNA microarrays
Bioinformatics · 2001 · 4,180 citations
Molecular portraits of human breast tumours
Nature · 2000 · 16,173 citations
Identification of Genes Periodically Expressed in the Human Cell Cycle and Their Expression in Tumors
Molecular Biology of the Cell · 2002 · 1,593 citations
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
New England Journal of Medicine · 2004 · 6,318 citations
Identifying biological themes within lists of genes with EASE
Genome biology · 2003 · 1,955 citations
Gene expression profiling predicts clinical outcome of breast cancer
Nature · 2002 · 9,574 citations
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
Proceedings of the National Academy of Sciences · 2001 · 10,888 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.
